The behavioral pharmacological profile of a drug in a pertinent species is necessary to evaluate quantitatively how the drug functions as a reinforcer. Ongoing studies on the direct behavioral effects of drugs include a number of different paradigms. The study of the stimulus effects of a drug most often involves training animals with a drug as a discriminative stimulus. One project involves the assessment of both the acute and chronic effects of a variety of drugs on these discriminative stimulus functions. We have shown that a combination of fenfluramine (FEN) and phentermine (PHEN), which has previously been reported to be useful in the treatment of alcohol and cocaine addictions, can serve as a discriminative stimulus. Each of the separate components of the mixture was found to contribute equally toward the cue in an additive manner, without showing similarities to other abused substances (e.g. alcohol, cocaine, etc). In vivo microdialysis experiments confirmed the nature of interaction; FEN and PHEN selectively increased serotonin and dopamine respectively, while the mixture increased both amines by similar levels. Therefore the dual stimulation of the amines by the mixture may be the basis for the cueing effects of the drug mixture. Locomotor activity is also used to assess the behavioral effects of drug treatment. Chronic administration of cocaine has been shown to produce long-lasting and progressive enhancements in their locomotor effects. It has been suggested that understanding of the neurobiological mechanisms of this sensitization may provide insight into the neural substrates mediated drug-induced psychosis. We recently reported that repeated once daily intravenous injections of cocaine produces locomotor sensitization. Dopamine D1 and D2 dopamine receptor antagonists are more potent in blocking cocaine's locomotor effects in cocaine-naive animals than in cocaine-sensitized animals. While a withdrawal effect is often times hard to observe following treatment with psychomotor stimulants, we have recently observed a withdrawal effect following chronic amphetamine treatment on locomotor activity. Rats treated for 2 weeks with amphetamine show a disruption in stereotypy 24-48 hours following the cessation of treatment. This disruption is correlated with a number of changes in brain transcription factors, suggesting neural correlates to the observed behavioral effect can be determined

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Intramural Research (Z01)
Project #
1Z01DA000003-10
Application #
5201635
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
10
Fiscal Year
1995
Total Cost
Indirect Cost
Name
National Institute on Drug Abuse
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Mazzola, Carmen; Medalie, Julie; Scherma, Maria et al. (2009) Fatty acid amide hydrolase (FAAH) inhibition enhances memory acquisition through activation of PPAR-alpha nuclear receptors. Learn Mem 16:332-7
Justinova, Zuzana; Munzar, Patrik; Panlilio, Leigh V et al. (2008) Blockade of THC-seeking behavior and relapse in monkeys by the cannabinoid CB(1)-receptor antagonist rimonabant. Neuropsychopharmacology 33:2870-7
Le Foll, Bernard; Forget, Benoit; Aubin, Henri-Jean et al. (2008) Blocking cannabinoid CB1 receptors for the treatment of nicotine dependence: insights from pre-clinical and clinical studies. Addict Biol 13:239-52
Le Foll, Bernard; Justinova, Zuzana; Tanda, Gianlugi et al. (2008) [Future medications for tobacco and cannabis dependence] Bull Acad Natl Med 192:45-56;discussion 56-7
Ferre, Sergi; Ciruela, Francisco; Borycz, Janusz et al. (2008) Adenosine A1-A2A receptor heteromers: new targets for caffeine in the brain. Front Biosci 13:2391-9
Panlilio, Leigh V; Solinas, Marcello; Matthews, Stephanie A et al. (2007) Previous exposure to THC alters the reinforcing efficacy and anxiety-related effects of cocaine in rats. Neuropsychopharmacology 32:646-57
Solinas, Marcello; Tanda, Gianluigi; Justinova, Zuzana et al. (2007) The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport. J Pharmacol Exp Ther 321:370-80
Ferre, S; Diamond, I; Goldberg, S R et al. (2007) Adenosine A2A receptors in ventral striatum, hypothalamus and nociceptive circuitry implications for drug addiction, sleep and pain. Prog Neurobiol 83:332-47
Solinas, Marcello; Yasar, Sevil; Goldberg, Steven R (2007) Endocannabinoid system involvement in brain reward processes related to drug abuse. Pharmacol Res 56:393-405
Solinas, Marcello; Scherma, Maria; Tanda, Gianluigi et al. (2007) Nicotinic facilitation of delta9-tetrahydrocannabinol discrimination involves endogenous anandamide. J Pharmacol Exp Ther 321:1127-34

Showing the most recent 10 out of 103 publications